Roche Holding AG (RHHBF) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - General Branche. Der Hauptsitz des Unternehmens ist in Basel, Switzerland. Der aktuelle CEO ist Thomas Schinecker.
RHHBF hat IPO-Datum 2012-08-03, 103,249 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $333.13B.
Roche Holding AG is a Swiss-based pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, immunology, cardiovascular, ophthalmology, and respiratory diseases, as well as treatments for conditions such as cancer, hemophilia, and inflammatory disorders. Roche also operates a substantial diagnostics business providing in vitro testing for disease diagnosis, including cancer, diabetes, COVID-19, and hepatitis, alongside diagnostic instruments and reagents. With operations spanning Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and other international markets, Roche maintains research collaborations to develop innovative therapies, including synthetic biologics for inflammatory bowel disease treatment.
